News

Thursday December 25th
December 23, 2025
Sports
December 24, 2025
Thursday December 25th
December 23, 2025
Sports
December 24, 2025
News

News

December 24, 2025

TrumpRx Launch: Major Pharma SHOCKED by Price Cuts

President Trump just slashed prescription drug prices by up to 85% overnight, forcing Big Pharma to match foreign lows or face crippling tariffs—what happens when America finally fights back?

Story Snapshot

  • TrumpRx.gov launches as direct-to-consumer platform offering brand-name drugs at Most-Favored-Nation prices from other nations.
  • Pfizer signs first deal; Eli Lilly, Novo Nordisk follow, dropping GLP-1 drugs like Ozempic to $350 monthly, trending to $245.
  • 100% tariffs on imported drugs start October 1 unless manufacturers build U.S. factories, tying price cuts to American jobs.
  • Bypasses insurers and PBMs for immediate uninsured access, with Medicare/Medicaid integrations saving taxpayers billions.
  • Five manufacturers committed by November 2025, full rollout early 2026 promises “impossible” reductions.

Trump’s Tariff Hammer Forces Pharma Compliance

President Donald J. Trump posted on Truth Social September 25, 2025, imposing 100% tariffs on imported branded drugs effective October 1 unless companies commit to U.S. manufacturing. Manufacturers faced a stark choice: match prices other developed nations pay or lose U.S. market access. Pfizer struck the first Most-Favored-Nation deal September 30, securing tariff exemptions by pledging domestic investments. This executive leverage revived Trump’s 2020 MFN rule, scrapped by Biden, but escalated with direct threats. American patients stand to gain while factories return home.

Eli Lilly and Novo Nordisk quickly followed, agreeing to TrumpRx pricing for GLP-1 weight loss drugs like Ozempic and Wegovy. These medications dropped from $1,000-$1,350 monthly to $350, with projections to $245. Five total agreements by November 6 secured partial MFN terms and U.S. construction timelines. Common sense dictates this works: tariffs protect American interests, rewarding compliance with exemptions while punishing profiteering.

WALL STREET JOURNAL | Consumers Power Strongest U.S. Economic Growth in Two Years

The U.S. economy expanded at a 4.3% annual rate in the third quarter of 2025, its fastest pace in two years, driven largely by strong consumer spending, rising exports, and increased government outlays.

FOX NEWS | Trump unveils ‘Golden Fleet’ of Navy battleships, touts them as ‘more powerful than any’ ever built

President Trump unveiled a new “Golden Fleet” of Navy battleships he says are more powerful than any ever built, emphasizing the advanced capabilities and firepower as part of his push to strengthen U.S. military dominance and national security.

BREITBART | Poll: Trump’s Approval Rating Lands at 50 Percent, 9 Points Above Water

A new InsiderAdvantage poll shows President Trump’s approval rating at 50 percent with a net approval of +9 points, marking a rebound to one of his highest ratings in months.

WASHINGTON TIMES | Trump’s top 10 achievements in 2025

The Washington Times lists President Trump’s top 10 accomplishments in 2025—including imposing “Liberation Day” tariffs to boost U.S. manufacturing, tightening immigration enforcement, securing historic job and economic growth, advancing peace negotiations abroad, and expanding U.S. energy and national security efforts—as key highlights of his year in office.

 
 
 
 

 

 
 
 
 
 

.

 
 
 
 
 
X icon
Instagram icon